{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:15:21Z","timestamp":1760919321564,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.htct.2025.103982","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:46:57Z","timestamp":1758091617000},"page":"103982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in the public Chilean national health system: A single center study"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-6987","authenticated-orcid":false,"given":"Barbara","family":"Puga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Bass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javiera","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Majlis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-3871","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2025.103982_bib0001","doi-asserted-by":"crossref","unstructured":"Lang, P., Greil, J., Bader, P., Handgretinger, R., Klingebiel, T., Schumm, M., et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood cells Mol Dis, 33(3), 281\u2013287. https:\/\/doi.org\/10.1016\/j.bcmd.2004.08.017.","DOI":"10.1016\/j.bcmd.2004.08.017"},{"key":"10.1016\/j.htct.2025.103982_bib0002","doi-asserted-by":"crossref","unstructured":"Palma, J., Salas, L., Carri\u00f3n, F., Sotomayor, C., Catal\u00e1n, P., et al. Haploidentical stem cell transplantation for children with high-risk leukemia. Pediatr Blood Cancer, 59(5), 895\u2013901. https:\/\/doi.org\/10.1002\/pbc.24022.","DOI":"10.1002\/pbc.24022"},{"key":"10.1016\/j.htct.2025.103982_bib0003","doi-asserted-by":"crossref","unstructured":"Luznik, L., Jalla, S., Engstrom, L.W., Iannone, R., & Fuchs, E.J. Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood, 98(12), 3456\u20133464. https:\/\/doi.org\/10.1182\/blood.v98.12.3456","DOI":"10.1182\/blood.V98.12.3456"},{"key":"10.1016\/j.htct.2025.103982_bib0004","doi-asserted-by":"crossref","unstructured":"Meybodi, M.A., Cao, W., Luznik, L., Bashey, A., Zhang, X., et al. HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis. Blood Adv, 3(17), 2581\u20132585. https:\/\/doi.org\/10.1182\/bloodadvances.2019000614","DOI":"10.1182\/bloodadvances.2019000614"},{"key":"10.1016\/j.htct.2025.103982_bib0005","doi-asserted-by":"crossref","unstructured":"Shem-Tov, N., Peczynski, C., Labopin, M., It\u00e4l\u00e4-Remes, M., Blaise, D., et al. Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT. Leukemia, 34(1), 283\u2013292. https:\/\/doi.org\/10.1038\/s41375-019-0544-3","DOI":"10.1038\/s41375-019-0544-3"},{"key":"10.1016\/j.htct.2025.103982_bib0006","doi-asserted-by":"crossref","unstructured":"Sanz, J., Galimard, J.E., Labopin, M., Afanasyev, B., Sergeevich, M.I., et al. Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT. J Hematol Oncol, 14(1), 84. https:\/\/doi.org\/10.1186\/s13045-021-01094-2","DOI":"10.1186\/s13045-021-01094-2"},{"key":"10.1016\/j.htct.2025.103982_bib0007","doi-asserted-by":"crossref","unstructured":"Nagler, A., Labopin, M., Houhou, M., Aljurf, M., Mousavi, A., et al. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the acute leukemia working party of the European society for blood and marrow transplantation. J Hematol Oncol, 14(1), 53. https:\/\/doi.org\/10.1186\/s13045-021-01065-7","DOI":"10.1186\/s13045-021-01065-7"},{"key":"10.1016\/j.htct.2025.103982_bib0008","doi-asserted-by":"crossref","unstructured":"Correa, C., Gonzalez-Ramella, O., Baldomero, H., Basquiera, A.L., Baena, R., et al. Worldwide network for blood and marrow transplantation (WBMT) increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Bone Marrow Transplant, 57(6), 881\u2013888. https:\/\/doi.org\/10.1038\/s41409-022-01630-9","DOI":"10.1038\/s41409-022-01630-9"},{"issue":"7","key":"10.1016\/j.htct.2025.103982_bib0009","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"European society for blood and marrow transplantation (EBMT). Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.htct.2025.103982_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.htct.2019.01.010","article-title":"Haploidentical transplantation outcomes are comparable with those obtained with identical human leukocyte antigen allogeneic transplantation in Chilean patients with benign and malignant hemopathies","volume":"42","author":"Sarmiento","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"issue":"4","key":"10.1016\/j.htct.2025.103982_bib0011","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR SEVERITY INDEx for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.htct.2025.103982_bib0012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.htct.2025.103982_bib0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2025.103982_bib0014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2025.103982_bib0015","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.htct.2025.103982_bib0016","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.htct.2025.103982_bib0017","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.htct.2025.103982_bib0018","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.htct.2025.103982_bib0019","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.htct.2025.103982_bib0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41409-021-01550-0","volume":"57","author":"Swoboda","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"28","key":"10.1016\/j.htct.2025.103982_bib0021","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1200\/JCO.2013.48.8114","volume":"31","author":"Nagler","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.htct.2025.103982_bib0022","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbmt.2016.12.628","article-title":"Alternative donor transplantation with high-dose post-transplantation cyclophosphamide for refractory severe aplastic anemia","volume":"23","author":"DeZern","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.htct.2025.103982_bib0023","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2019.01.010","article-title":"Comparable outcome with a faster engraftment of optimized haploidentical hematopoietic stem cell transplantation compared with transplantations from other donor types in pediatric acquired aplastic anemia","volume":"25","author":"Kim","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.htct.2025.103982_bib0024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.htct.2025.103982_bib0025","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/s41409-019-0500-x","article-title":"Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients","volume":"54","author":"Granata","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"10.1016\/j.htct.2025.103982_bib0026","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","article-title":"Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-Cell-Replete haploidentical donor transplantation using post-transplant cyclophosphamide","volume":"35","author":"Bashey","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.htct.2025.103982_bib0027","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41409-018-0279-1","article-title":"Japan study group for cell therapy and transplantation (JSCT). Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide","volume":"54","author":"Sugita","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.htct.2025.103982_bib0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-020-00882-6","volume":"13","author":"Sanz","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.htct.2025.103982_bib0029","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bbmt.2020.05.001","article-title":"Risk factors for Graft-versus-Host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide","volume":"26","author":"Im","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.htct.2025.103982_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.01.020","article-title":"Grupo Espa\u00f1ol de Trasplante Hematopoy\u00e9tico y Terapia Celular (GETH). Post-Transplantation Cyclophosphamide After HLA identical compared to haploidentical donor transplant in acute myeloid leukemia: a study on behalf of GETH-TC","volume":"28","author":"Bail\u00e9n","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.htct.2025.103982_bib0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","article-title":"A risk score for mortality after allogeneic hematopoietic cell transplantation","volume":"144","author":"Parimon","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.htct.2025.103982_bib0032","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0609.2011.01627.x","article-title":"Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study","volume":"87","author":"Gonz\u00e1lez-Vicent","year":"2011","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.htct.2025.103982_bib0033","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.30249","article-title":"Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia","volume":"139","author":"Mo","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.htct.2025.103982_bib0034","volume":"11","author":"Moreno","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.htct.2025.103982_bib0035","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41409-024-02400-5","volume":"59","author":"Nagler","year":"2024","journal-title":"Bone Marrow Transplant"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T07:22:55Z","timestamp":1760858575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2531137925002470"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.103982","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in the public Chilean national health system: A single center study","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.103982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103982"}}